HomeTracker, L.P. – Trademark Portfolio

Entity Type: 13

HomeTracker, L.P. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HOMETELOS and HOMETRACKER. The owner is based in Addison, TX.

15851 Dallas Parkway, Suite 308

Addison, TX 75001

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

HomeTracker, L.P.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (8 filings)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does HomeTracker, L.P. have?

HomeTracker, L.P. has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 4 cancelled.

What trademark classes does HomeTracker, L.P. file in?

HomeTracker, L.P. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.

What are HomeTracker, L.P.'s most well-known trademarks?

HomeTracker, L.P.'s registered trademark portfolio includes well-known marks such as HOMETELOS and HOMETRACKER. These are among 2 currently registered trademarks in the portfolio.

What is HomeTracker, L.P.'s trademark registration success rate?

HomeTracker, L.P. has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.